En un esfuerzo por fortalecer su negocio bioracional, Valent BioSciences Corp., una subsidiaria estadounidense de propiedad total de Sumitomo Chemical, ha firmado un acuerdo de licencia global con LidoChem y un acuerdo de cooperación para el desarrollo y la comercialización con Rizobacter, con sede en Argentina.
This is the next step in Valent’s efforts to expand its biorational business in the U.S. which began with the opening a fermentation manufacturing facility in 2014 followed by the acquisition of Mycorrhizal Applications LLC, a producer of mycorrhizal fungal inoculum, in 2015. The company also plans to build a research facility in Illinois, U.S.A. Sumitomo Chemical has also taken steps to strengthen its global agriculture-related business by integrating its plant protection chemicals business and VBC’s biorational business.
Más en Sumitomo’s plans.